Global Cancer Biomarkers Market 2012-2016


◆タイトル:Global Cancer Biomarkers Market 2012-2016
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆資料形式:pdf / 英語
Single UserUSD2,000 ⇒換算¥218,000見積依頼/購入/質問フォーム
Five UserUSD2,300 ⇒換算¥250,700見積依頼/購入/質問フォーム
Enterprise License(社内共有可)USD3,000 ⇒換算¥327,000見積依頼/購入/質問フォーム
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。



TechNavio’s analysts forecast the Global Cancer Biomarkers market to grow at a CAGR of 18.22 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing prevalence of cancer. The Global Cancer Biomarkers market has also been witnessing the trend of the emergence of personalized medicines. However, the poor regulatory and reimbursement systems could pose a challenge to the growth of this market.

TechNavio’s report, the Global Cancer Biomarkers market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Cancer Biomarkers market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this market space are Abbott Laboratories, Affymetrix, Inc., Agilent Technologies Inc., Gen-Probe Inc., Hologic, Inc., and Roche Diagnostics Corp.

The other vendors mentioned in the report are Agendia BV, Ambrilia Biopharma, Astellas Pharma US Inc., Morphotek, Inc., Gen-Probe, Inc., Veridex LLC, Morphotek, Inc., Immunomedics, Inc., Clarient, Inc.

Key questions answered in this report:
What will the market size be in 2016 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?


01. Executive Summary
02. Introduction
03. Market Coverage
Market Overview
04. Market Landscape
Market Size and Forecast
04.1 Five Forces Analysis
05. Geographical Segmentation
06. Rate of Incidence and Prevalence
07. Vendor Landscape
08. Buying Criteria
09. Market Growth Drivers
10. Drivers and Their Impact
11. Market Challenges
12. Impact of Drivers and Challenges
13. Market Trends
14. Key Vendor Analysis
14.1 Abbott Laboratories
Business Overview
SWOT Analysis
14.2 Affymetrix Inc.
Business Overview
SWOT Analysis
14.3 Agilent Technologies Inc.
Business Overview
SWOT Analysis
14.4 Hologic Inc.
Business Overview
SWOT Analysis
14.5 Roche Diagnostics Corp.
Business Overview
SWOT Analysis
15. Other Reports in this Series

List of Exhibits:
Exhibit 1: Global Cancer Biomarkers Market 2012-2016 (US$ million)
Exhibit 2: Global Cancer Biomarkers Market by Geographical Segmentation 2012


Abbott Laboratories, Affymetrix, Agilent Technologies, Gen-Probe, Hologic, Roche Diagnostics, Agendia, Ambrilia Biopharma, Astellas Pharma US, Morphotek, Gen-Probe, Veridex, Morphotek, Immunomedics, Clarient



★調査レポート[世界の癌バイオマーカー市場動向(2012-2016)] (Global Cancer Biomarkers Market 2012-2016 / IRTNTR1841)販売に関する免責事項
[世界の癌バイオマーカー市場動向(2012-2016)] (Global Cancer Biomarkers Market 2012-2016 / IRTNTR1841)についてEメールでお問い合わせ